Open access · CC-BY
via OpenAlex
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Elham Nasiri, Roman Sankowski, Henriette Dietrich, Aikaterini Oikonomidi, Patricio T. Huerta, Julius Popp, Yousef Al‐Abed, Michael Bacher
Molecular Medicine · 2020 · ▲ 88 citations
Abstract
BACKGROUND: Macrophage Migration Inhibitory Factor (MIF) is a potent proinflammatory cytokine that promotes the production of other immune mediators. MIF is produced by most cell types in the brain including microglia, astrocytes and neurons. Enhanced expression of MIF might contribute to the persistent activation of glial, chronic neuroinflammation and neurodegeneration. Here, we investigated the effect of MIF on inflammatory markers and spatial learning in a mouse model of sporadic AD and on tau pathology in AD patients. METHODS: We examined the effects of MIF deficiency and pharmacological MIF inhibition in vitro and in vivo. In vitro, quantitative PCR and ELISA were used to assess cytokine production of STZ-treated glial cells. In vivo, C57BL/6 mice were subjected to intracerebroventricular streptozotocin injection (3 mg/kg, ICV-STZ). Neuroinflammation and contextual learning performance were assessed using quantitative PCR and fear conditioning, respectively. Pharmacological MIF inhibition was achieved with intraperitoneal injections of ISO-1 (daily, IP, 20 mg/kg in 5% DMSO in 0.9% NaCl) for 4 weeks following ICV-STZ injection. The findings from ISO-1 treated mice were confirmed in MIF knockout C57BL/6. To assess the role of MIF in human AD, cerebrospinal fluid levels of MIF and hyperphosphorylated tau were measured using ELISA. RESULTS: Administration ICV-STZ resulted in hippocampal dependent cognitive impairment. MIF inhibition with ISO-1 significantly improved the STZ-induced impairment in contextual memory performance, indicating MIF-related inflammation as a major contributor to ICV-STZ-induced memory deficits. Furthermore, inhibition of the MIF resulted in reduced cytokine production in vitro and in vivo. In human subjects with AD at early clinical stages, cerebrospinal fluid levels of MIF were increased in comparison with age-matched controls, and correlated with biomarkers of tau hyper-phosphorylation and neuronal injury hinting at MIF levels as a potential biomarker for early-stage AD. CONCLUSIONS: The present study indicates the key role of MIF in controlling the chronic cytokine release in neuroinflammation related to tau hyperphosphorylation, neurodegeneration, and clinical manifestations of AD, suggesting the potential of MIF inhibition as therapeutic strategy to slow down neurodegeneration and clinical disease progression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s10020-020-00163-5
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Nasiri, E., Sankowski, R., Dietrich, H., Oikonomidi, A., Huerta, P.T., Popp, J., Al‐Abed, Y., & Bacher, M. (2020). Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease. <em>Molecular Medicine</em>. https://doi.org/10.1186/s10020-020-00163-5
Vancouver
Nasiri E, Sankowski R, Dietrich H, Oikonomidi A, Huerta PT, Popp J, et al. Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease. Molecular Medicine. 2020. doi:10.1186/s10020-020-00163-5.
BibTeX
@article{elham2020Keyrol,
title = {Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease},
author = {Elham Nasiri and Roman Sankowski and Henriette Dietrich and Aikaterini Oikonomidi and Patricio T. Huerta and Julius Popp and Yousef Al‐Abed and Michael Bacher},
journal = {Molecular Medicine},
year = {2020},
doi = {10.1186/s10020-020-00163-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neural Regeneration Research 2019
Open access · CC-BY
Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease
Neurobiology of Aging 2021
Preprint · OA
Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age
Neuro-Oncology 2019
Preprint · OA
Radiation-induced astrocyte senescence is rescued by Δ133p53
2026
Open access · OA
Telomerase in brain and neurodegeneration
Nucleus 2016
Open access · CC-BY
Alzheimer's disease: An acquired neurodegenerative laminopathy
Annals of Neurology 2013
Preprint · OA